Immunoinflammatory diseases such as AU, IBD and RA are characterized by abnormal PIM1 expression, which can affect the development of inflammatory diseases by mediating inflammatory signaling pathways, classical macrophage activation, and imbalances between effector T cells. This evidence concerns the gene PIM1 and rheumatoid arthritis.